diazoxide has been researched along with Kidney Diseases in 14 studies
Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A survey of UK patients receiving the drug diazoxide, revealed 40 patients with insulinoma on this treatment." | 7.69 | Diazoxide treatment for insulinoma: a national UK survey. ( Gill, GV; MacFarlane, IA; Rauf, O, 1997) |
| " have applied the diazoxide test for the screening of primary hiperaldosteronism to 22 nephropatic patients suffering from hypertension and with different degrees of renal function." | 7.65 | [Diazoxide test in the diagnosis of arterial hypertension: modifications in the levels of renin and aldosterone in blood of patients with various restrains of the renal function]. ( Albertini, A; Cecchettin, M; Ghielmi, S; Maiorca, R; Orlandini, A; Signorini, C, 1975) |
| "A survey of UK patients receiving the drug diazoxide, revealed 40 patients with insulinoma on this treatment." | 3.69 | Diazoxide treatment for insulinoma: a national UK survey. ( Gill, GV; MacFarlane, IA; Rauf, O, 1997) |
| " have applied the diazoxide test for the screening of primary hiperaldosteronism to 22 nephropatic patients suffering from hypertension and with different degrees of renal function." | 3.65 | [Diazoxide test in the diagnosis of arterial hypertension: modifications in the levels of renin and aldosterone in blood of patients with various restrains of the renal function]. ( Albertini, A; Cecchettin, M; Ghielmi, S; Maiorca, R; Orlandini, A; Signorini, C, 1975) |
| "Propofol treatments were initiated at various time intervals: 1 or 24 h before ischemia, only during ischemia, or only during reperfusion." | 1.35 | The role of KATP channels on propofol preconditioning in a cellular model of renal ischemia-reperfusion. ( Assad, AR; Capella, MA; Delou, JM; Fonseca, LM; Lopes, AG; Nascimento, JH; Verçosa, N; Villela, NR, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (64.29) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 2 (14.29) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yilmaz, TU | 1 |
| Yazihan, N | 1 |
| Dalgic, A | 1 |
| Kaya, EE | 1 |
| Salman, B | 1 |
| Kocak, M | 1 |
| Akcil, E | 1 |
| Assad, AR | 1 |
| Delou, JM | 1 |
| Fonseca, LM | 1 |
| Villela, NR | 1 |
| Nascimento, JH | 1 |
| Verçosa, N | 1 |
| Lopes, AG | 1 |
| Capella, MA | 1 |
| Sun, Z | 1 |
| Zhang, X | 1 |
| Ito, K | 1 |
| Li, Y | 1 |
| Montgomery, RA | 1 |
| Tachibana, S | 1 |
| Williams, GM | 1 |
| Reeves, WB | 1 |
| Shah, SV | 1 |
| Gill, GV | 1 |
| Rauf, O | 1 |
| MacFarlane, IA | 1 |
| Lowenthal, DT | 1 |
| Rowe, WS | 1 |
| Woods, JR | 1 |
| Brinkman, CR | 1 |
| Cecchettin, M | 1 |
| Albertini, A | 1 |
| Ghielmi, S | 1 |
| Signorini, C | 1 |
| Orlandini, A | 1 |
| Maiorca, R | 1 |
| Birkenhäger, WH | 1 |
| Wester, A | 1 |
| Pohl, JE | 2 |
| Thurston, H | 2 |
| Swales, JD | 1 |
| Schiff, D | 1 |
| Colle, E | 1 |
| Wells, D | 1 |
| Stern, L | 1 |
| Gotlin, RW | 1 |
14 other studies available for diazoxide and Kidney Diseases
| Article | Year |
|---|---|
Role of ATP-dependent K channels in the effects of erythropoietin in renal ischaemia injury.
Topics: Apoptosis; Cell Line; Cell Proliferation; Diazoxide; Erythropoietin; Gene Expression Regulation; Hum | 2015 |
The role of KATP channels on propofol preconditioning in a cellular model of renal ischemia-reperfusion.
Topics: Adenosine Triphosphate; Animals; Antimycin A; Apoptosis; Cell Survival; Cytoprotection; Decanoic Aci | 2009 |
Amelioration of oxidative mitochondrial DNA damage and deletion after renal ischemic injury by the KATP channel opener diazoxide.
Topics: Animals; Apoptosis; Diazoxide; DNA, Mitochondrial; Free Radicals; Kidney Diseases; Kidney Function T | 2008 |
Activation of potassium channels contributes to hypoxic injury in proximal tubules.
Topics: Adenosine Triphosphate; Animals; Biological Transport; Diazoxide; DNA Damage; Dose-Response Relation | 1994 |
Diazoxide treatment for insulinoma: a national UK survey.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Diazoxide; Female; Health Care Surveys; Hum | 1997 |
Hypertensive crisis and postcrisis management.
Topics: Antihypertensive Agents; Brain Diseases; Diazoxide; Glomerular Filtration Rate; Hemodynamics; Humans | 1978 |
Some aspects of the management of hypertension II. Special considerations.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure Determination; Diazoxide; Drug Therapy, Combina | 1975 |
The treatment of gestational hypertension.
Topics: Antihypertensive Agents; Chronic Disease; Diazoxide; Female; Humans; Hydralazine; Hypertension; Hype | 1975 |
[Diazoxide test in the diagnosis of arterial hypertension: modifications in the levels of renin and aldosterone in blood of patients with various restrains of the renal function].
Topics: Adolescent; Adult; Aldosterone; Diazoxide; Humans; Hyperaldosteronism; Hypertension; Kidney Diseases | 1975 |
[A question of logic].
Topics: Diazoxide; Furosemide; Humans; Hyperaldosteronism; Hypertension; Kidney Diseases; Male; Middle Aged; | 1976 |
Hypertension with renal impairment: influence of intensive therapy.
Topics: Adolescent; Adult; Chronic Disease; Creatinine; Diazoxide; Female; Glomerulonephritis; Humans; Hyper | 1974 |
Metabolic aspects of the Beckwith-Wiedemann syndrome.
Topics: Abnormalities, Multiple; Adrenal Gland Diseases; Blood Glucose; Child, Preschool; Diazoxide; Epineph | 1973 |
Diazoxide therapy in the syndrome of Beckwith-Weidemann-Coombs.
Topics: Abnormalities, Multiple; Adrenal Gland Diseases; Blood Glucose; Child, Preschool; Diazoxide; Epineph | 1973 |
The use of diazoxide in hypertension with renal damage.
Topics: Diazoxide; Humans; Hypertension, Malignant; Kidney Diseases | 1971 |